Molecular Bioengineering in health ERA chair

MOBILIsE aims to recruit an outstanding Researcher to act as the ERA Chair Holder to the National Institute of Biomedical Engineering (INEB).

She/he will establish a new research direction in Molecular Bioengineering focused on precision medicine, namely in targeted therapies and molecular diagnosis, and create a synergic and cohesive research environment among key stakeholders (academy, research institutes, clinicians and industry) in the Porto region: the MOBILIsE hub.

The MOBILIsE project will boost the translation of the design of new molecular targets to the application of diagnostic tools and therapies targeted to the major health challenges, with particular focus on cancer, infection, neurodegenerative diseases, and tissue repair/regeneration that have been explored at the institute.

INEB is already recognized for its fundamental work in protein/cell-materials interactions and in the development of nanotechnology tools for targeted controlled drug delivery.

Yet, the potential and projection at international level of cross-disciplinary research, like the application of nanomedicine to cancer and neurologic disorders, is still limited.

This has a major impact on funding attraction, transfer of technology, and translational potential of the research developed.

Hence, this project will hire an expert in Molecular Bioengineering to install an internationally competitive research group focused on precision medicine.

The group will exploit nanotechnology tools to discover new molecular targets that can be explored in the design of new diagnostic and/or therapeutic systems.

The MOBILIsE project will promote the integration between biomedical engineering, biology and medicine, by focusing on (vital) interactions at the molecular level with impact on human health.

Ultimately, MOBILIsE aims to establish a Molecular Bioengineering research group that will facilitate critical institutional structural changes to maximize the high potential for research excellence at INEB.